Invex Therapeutics (Australia) Market Value
| IXC Stock | 0.07 0.01 13.33% |
| Symbol | Invex |
Invex Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Invex Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Invex Therapeutics.
| 01/27/2025 |
| 02/26/2025 |
If you would invest 0.00 in Invex Therapeutics on January 27, 2025 and sell it all today you would earn a total of 0.00 from holding Invex Therapeutics or generate 0.0% return on investment in Invex Therapeutics over 30 days. Invex Therapeutics is related to or competes with Argo Investments, Alternative Investment, Pinnacle Investment, Homeco Daily, and TPG Telecom. Invex Therapeutics is entity of Australia More
Invex Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Invex Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Invex Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 20.8 | |||
| Value At Risk | (5.41) | |||
| Potential Upside | 4.17 |
Invex Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Invex Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Invex Therapeutics' standard deviation. In reality, there are many statistical measures that can use Invex Therapeutics historical prices to predict the future Invex Therapeutics' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.18) | |||
| Treynor Ratio | 0.5768 |
Invex Therapeutics Backtested Returns
Invex Therapeutics holds Efficiency (Sharpe) Ratio of close to zero, which attests that the entity had a close to zero % return per unit of risk over the last 3 months. Invex Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Invex Therapeutics' Standard Deviation of 2.97, market risk adjusted performance of 0.5868, and Risk Adjusted Performance of (0.04) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.35, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Invex Therapeutics are expected to decrease at a much lower rate. During the bear market, Invex Therapeutics is likely to outperform the market. At this point, Invex Therapeutics has a negative expected return of -0.0075%. Please make sure to check out Invex Therapeutics' maximum drawdown, skewness, daily balance of power, as well as the relationship between the potential upside and kurtosis , to decide if Invex Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.87 |
Excellent reverse predictability
Invex Therapeutics has excellent reverse predictability. Overlapping area represents the amount of predictability between Invex Therapeutics time series from 27th of January 2025 to 11th of February 2025 and 11th of February 2025 to 26th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Invex Therapeutics price movement. The serial correlation of -0.87 indicates that approximately 87.0% of current Invex Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.87 | |
| Spearman Rank Test | -0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Invex Therapeutics lagged returns against current returns
Autocorrelation, which is Invex Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Invex Therapeutics' stock expected returns. We can calculate the autocorrelation of Invex Therapeutics returns to help us make a trade decision. For example, suppose you find that Invex Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Invex Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Invex Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Invex Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Invex Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Invex Therapeutics Lagged Returns
When evaluating Invex Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Invex Therapeutics stock have on its future price. Invex Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Invex Therapeutics autocorrelation shows the relationship between Invex Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Invex Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Invex Stock Analysis
When running Invex Therapeutics' price analysis, check to measure Invex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invex Therapeutics is operating at the current time. Most of Invex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Invex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invex Therapeutics' price. Additionally, you may evaluate how the addition of Invex Therapeutics to your portfolios can decrease your overall portfolio volatility.